As a holding subsidiary of Tigermed (300347.SZ / 3347.HK) that is one of the top
listed clinical CRO in China, Teddylab is an one-stop clinical research laboratory service provider dedicated to pharmaceutical companies, biotechs, CROs and research
institutions with GCP compliance as well as international
standards.
Teddylab is CAP accredited and NGSP Level 1 certified central laboratory. We regularly participate the external quality assessment of China Health Planning Commission and Shanghai Clinical
Laboratory Center. Until June the 2024, Teddylab has participated more than 1500 registered clinical trials ranging from phase I to IV. We have worked together with sponsors to pass amount of on-site audits from CFDA and supported the approval of 44 new drugs in China. The therapeutic areas that Teddylab has profound of experience including radiopharmaceutical, immunotherapy, oncology, diabetes, hepatitis, cardiovascular diseases and
vaccines.
Moreover, Teddylab also provides a high standard one-stop central laboratory service for international multi regional clinical trials (MRCT) together with our oversea strategic partner central laboratories. Teddylab has supported more than 50 MRCT clinical trials in 10+ theapeutic fields with footprints in 26 countries.